Page last updated: 2024-08-21

bamifylline and tacrolimus

bamifylline has been researched along with tacrolimus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barilli, A; Bonomini, S; Bussolati, O; Closs, EI; Dall'Asta, V; Gazzola, GC; Parolari, A; Sala, R; Simon, A; Tremoli, E; Visigalli, R1

Other Studies

1 other study(ies) available for bamifylline and tacrolimus

ArticleYear
In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function.
    Cardiovascular research, 2008, Jun-01, Volume: 78, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blotting, Western; Cardiovascular Agents; Carrier Proteins; Caspase 3; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; E-Selectin; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Humans; Immunoprecipitation; L-Lactate Dehydrogenase; Mechanistic Target of Rapamycin Complex 1; Microscopy, Confocal; Multiprotein Complexes; Necrosis; Nitric Oxide; Nitric Oxide Synthase Type III; Polymerase Chain Reaction; Protein Kinases; Proteins; Rapamycin-Insensitive Companion of mTOR Protein; Regulatory-Associated Protein of mTOR; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Stress Fibers; Tacrolimus; Theophylline; Time Factors; TOR Serine-Threonine Kinases; Transcription Factors; Tumor Necrosis Factor-alpha; Up-Regulation

2008